Company news
Sol-Gel Technologies Ltd. news in 2023
Sol-Gel Technologies Ltd.'s news releases, calls and decks from 2023, newest first.
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study
November 29, 2023
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610
November 27, 2023
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 8, 2023
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
August 29, 2023
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 9, 2023
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada
June 5, 2023
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 11, 2023
Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
March 19, 2023
Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments
March 9, 2023
Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings
January 26, 2023
Sol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $300 Million
January 26, 2023
Decks in 2023
- Investor Presentation (February 2023)
Investor deck · 19 slides · Feb 2, 2023